Bifidobacterium animalis subsp. lactis XLTG11 improves antibiotic-related diarrhea by alleviating inflammation, enhancing intestinal barrier function and regulating intestinal flora.
- 2022-06-08
- Clinical Trial
- Food & Function 13(11)
- Baofeng Xu
- Shengnan Liang
- Jiayi Zhao
- Xuetong Li
- Jiayao Guo
- Bowen Xin
- Bailiang Li
- G. Huo
- Weiwei Ma
- PubMed: 35616024
- DOI: 10.1039/d1fo04305f
- Low evidence
- Animal Study
- Clinical
Moreover, after treatment with *B. lactis* XLTG11, the contents of acetic acid, propionic acid, butyric acid and total short-chain fatty acids were significantly increased.
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes